According to a new BioPharma Dive analysis, corporate-related funds such as Novo Holdings, Eli Lilly and Sanofi Ventures have ...
2don MSN
Eli Lilly, Nvidia partner to build supercomputer, AI factory for drug discovery and development
It's the latest stride by Nvidia and the pharmaceutical industry to harness AI to try to reduce costs and shorten the time it ...
The U.S. Cell-based Assays Market is Expanding Rapidly Due to Strong Pharmaceutical Activity, Technological Innovation, and Increasing Use in Drug Discovery and Toxicity Testing.Austin, Oct. 30, 2025 ...
INDIANAPOLIS, Sept. 9, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the launch of Lilly TuneLab, an artificial intelligence and machine learning (AI/ML) platform that ...
Japan biotech xFOREST Therapeutics is teaming up with a drug discovery solutions provider in a research pact aiming to develop new RNA structure-targeted small molecule therapeutics, including mRNA ...
The OpenFold Consortium, a leading nonprofit artificial intelligence (AI) research consortium, today announced a preview release of OpenFold3, an open-source deep learning model that predicts ...
Following three years of internal development, Expedition Medicines is taking flight. The company is supported by a $50 ...
WuXi AppTec, a global contract research, development, and manufacturing organization (CRDMO), recently hosted its 2025 ...
Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback